D. Aldrighetti
Impact in
- Cancer Research top 10%
- Breast Cancer Treatment Studies
-
- Cancer Treatment and Pharmacology
- COVID-19 and healthcare impacts
- HER2/EGFR in Cancer Research
Papers in
-
- Breast Cancer Treatment Studies 5
- Oncology 5
- Cancer Treatment and Pharmacology 2
- HER2/EGFR in Cancer Research 2
- COVID-19 and healthcare impacts 1
- Co-authors
- Angelo Bolognesi (3 shared papers)Francesco Boccardo (5 shared papers)P Sismondi (4 shared papers)A. Farris (4 shared papers)ALESSANDRA RUBAGOTTI (5 shared papers)DOMENICO AMOROSO (4 shared papers)Paolo Pacini (3 shared papers)Mario Mesiti (4 shared papers)
- Journals
- The Breast (2 papers)Cancer (2 papers)Journal of Clinical Oncology (1 paper)The Oncologist (1 paper)Critical Reviews in Oncology/Hematology (1 paper)
- Partner nations
- ItalyUnited StatesBelgium
In The Last Decade
D. Aldrighetti
12 papers receiving 333 citations
Peers
Comparison fields: 5 of 32
- Cancer Research 208
- Oncology 99
- Genetics 22
- Cardiology and Cardiovascular Medicine 17
- Pulmonary and Respiratory Medicine 21
Countries citing papers authored by D. Aldrighetti
This map shows the geographic impact of D. Aldrighetti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Aldrighetti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Aldrighetti more than expected).
Fields of papers citing papers by D. Aldrighetti
This network shows the impact of papers produced by D. Aldrighetti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Aldrighetti. The network helps show where D. Aldrighetti may publish in the future.
Co-authors
The 25 scholars most cited alongside D. Aldrighetti, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 139 | |
| 2 | 2004 | 54 | |
| 3 | 2020 | 31 | |
| 4 | 2004 | 26 | |
| 5 | 2007 | 25 | |
| 6 | 2013 | 20 | |
| 7 | 2012 | 19 | |
| 8 | 2010 | 18 | |
| 9 | 1993 | 8 | |
| 10 | 1996 | 8 | |
| 11 | 2024 | 8 | |
| 12 | Tolerability of sunitinib in combination with docetaxel and trastuzumab as first-line therapy for HER2+advanced breast cancer : Abstract #4120 | 2009 | 1 |
| 13 | 1997 | 0 | |
| 14 | 2023 | 0 |
About D. Aldrighetti
D. Aldrighetti is a scholar working on Cancer Research, Oncology, Surgery, Cardiology and Cardiovascular Medicine and Genetics, having authored 14 papers that have together received 357 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (5 papers), Nausea and vomiting management (2 papers), Cancer Treatment and Pharmacology (2 papers), HER2/EGFR in Cancer Research (2 papers), Chemotherapy-induced cardiotoxicity and mitigation (1 paper), COVID-19 and healthcare impacts (1 paper), Estrogen and related hormone effects (1 paper) and Angiogenesis and VEGF in Cancer (1 paper). The work is most often cited by research in Cancer Research (208 citations), Oncology (99 citations), Genetics (22 citations), Cardiology and Cardiovascular Medicine (17 citations) and Pulmonary and Respiratory Medicine (21 citations). D. Aldrighetti has collaborated with scholars based in Italy, United States and Belgium. Frequent co-authors include Angelo Bolognesi, Francesco Boccardo, P Sismondi, A. Farris, ALESSANDRA RUBAGOTTI, DOMENICO AMOROSO, Paolo Pacini, Mario Mesiti, Maurizia Giai and D Romeo. Their work appears in journals such as The Breast, Cancer, Journal of Clinical Oncology, The Oncologist and Critical Reviews in Oncology/Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.